COMT and Parkinson disease: PD treatments include levodopa (L-DOPA), a precursor of dopamine (DA); catechol-O-methyltransferase (COMT) and monoamine oxidase-B (MAO-B) inhibitors to prevent DA degradation; and dopamine D2 receptor agonists [5,6,7,8].